Becton Dickinson has announced a definitive agreement to acquire Enovis Corporation's robotics division for $2.1 billion, marking its entry into the fast-growing surgical robotics segment.
Becton, Dickinson and Company (BD) has entered into a definitive agreement to acquire the surgical robotics division of Enovis Corporation for approximately $2.1 billion in an all-cash transaction expected to close in Q3 2026.
The acquisition gives BD access to Enovis' ARVIS robotic guidance system for hip and knee arthroplasty, which has been used in over 45,000 procedures across 180 US hospitals since its launch in 2023.
Strategic Rationale
BD CEO Tom Polen stated the acquisition accelerates the company's strategy to build a comprehensive surgical solutions portfolio beyond its traditional focus on infection prevention and medication management.
- ARVIS system installed in 180+ US hospitals
- 45,000+ procedures completed to date
- Complements BD's existing Venclose and PhysioLogic portfolios
- Estimated $300M revenue synergies by 2028
The global surgical robotics market is projected to grow from $14.7 billion in 2025 to $38.4 billion by 2032, driven by rising demand for precision procedures and shorter hospital stays.
Enovis shareholders will receive a 28% premium over the 30-day volume-weighted average price.